Cureshot Pharmaceuticals And Research Center Private Limited - Company Profile

It is a pharma private limited company based in Surat, Gujarat, India, established in 2021.
2021 Surat, Gujarat, India Active
Last Updated:
Access Report
About Cureshot Pharmaceuticals And Research Center Private Limited

Cureshot Pharmaceuticals And Research Center Private Limited, a active private limited company, was established on 30 January 2021 in Surat, Gujarat, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24290GJ2021PTC119836. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Ajitkumar Virabhai Patel (Director), Nidhi Maheshkumar Desai (Director), Yatin Kumar Jagdishchandra Joshi (Director). Past directors included Ajitkumar Virabhai Patel, Nidhi Maheshkumar Desai. It holds ₹9.65 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 54,Parasnagar Rotlapir,Palanpur Road, Surat, Gujarat, 395009.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24290GJ2021PTC119836

  • Registration Number

    119836

  • Incorporation Date

    30 January 2021

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 5 Year, 1 Month
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 9.65 Cr
  • Revenue Growth **** %
  • Profit Growth **** -233.01%
  • Ebitda **** -290.36%
  • Net Worth -49.44%
  • Total Assets **** 47.53%
Company report

Cureshot Pharmaceuticals And Research Center Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Cureshot Pharmaceuticals And Research Center Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Cureshot Pharmaceuticals And Research Center Private Limited?
Current Directors
Name Designation Appointment Date Status
Ajitkumar Virabhai Patel Director 21 Jun 2021 Current
Nidhi Maheshkumar Desai Director 28 May 2021 Current
Yatin Kumar Jagdishchandra Joshi Director 30 Jan 2021 Current
Dharmin Yatinkumar Joshi Director 30 Jan 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 24 Feb 2023 Past
Pramod Abcsdd Additional Director 24 Feb 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Cureshot Pharmaceuticals And Research Center.

Cureshot Pharmaceuticals And Research Center Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 233.01% decrease in profit. The company's net worth observed a substantial decline by a decrease of 49.44%.

Cureshot Pharmaceuticals And Research Center revenue growth over time
Cureshot Pharmaceuticals And Research Center profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 47.53%
*******
*******
*******
*******
Profit or Loss
*******
 -233.01%
*******
*******
*******
*******
Net Worth
*******
 -49.44%
*******
*******
*******
*******
EBITDA
*******
 -290.36%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Cureshot Pharmaceuticals And Research Center?

In 2023, Cureshot Pharmaceuticals And Research Center had a public holding of 15.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹96,500,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Canara Bank : 9.65 Cr
Latest Charge Details
Date Lender Amount Status
03 Mar 2022 Canara Bank ₹9.65 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Cureshot Pharmaceuticals And Research Center?

Cureshot Pharmaceuticals And Research Center has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Cureshot Pharmaceuticals And Research Center, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cureshot Pharmaceuticals And Research Center's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Cureshot Pharmaceuticals And Research Center
Recent Activity within the Organization
  • Annual General Meeting

    The activity Cureshot Pharmaceuticals And Research Center Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Cureshot Pharmaceuticals And Research Center Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ahmedabad. was completed.

  • Charges

    Progress on A charge with Canara Bank amounted to Rs. 96.50 M with Charge ID 100552286 was registered on 03 Mar 2022. was documented.

  • Director Appointment

    The activity Ajitkumar Virabhai Patel was appointed as a Director was appointed as a Director on 21 Jun 2021 & has been associated with this company since 4 years 9 months . was completed.

  • Director Appointment

    Progress on Nidhi Maheshkumar Desai was appointed as a Director was appointed as a Director on 28 May 2021 & has been associated with this company since 4 years 10 months . was documented.

  • Director Appointment

    The activity Yatin Kumar Jagdishchandra Joshi was appointed as a Director was appointed as a Director on 30 Jan 2021 & has been associated with this company since 5 years 1 month . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Cureshot Pharmaceuticals And Research Center Private Limited?

The CIN of Cureshot Pharmaceuticals And Research Center Private Limited is U24290GJ2021PTC119836.

Where is Cureshot Pharmaceuticals And Research Center Private Limited headquartered?

Cureshot Pharmaceuticals And Research Center Private Limited is headquartered at 54,Parasnagar Rotlapir,Palanpur Road, Surat, Gujarat, 395009.

When was Cureshot Pharmaceuticals And Research Center Private Limited incorporated?

Cureshot Pharmaceuticals And Research Center Private Limited was incorporated on 30 January 2021.

Who are the current directors of Cureshot Pharmaceuticals And Research Center Private Limited?

The current directors of Cureshot Pharmaceuticals And Research Center Private Limited are

What is the primary industry of Cureshot Pharmaceuticals And Research Center Private Limited?

The primary industry of Cureshot Pharmaceuticals And Research Center Private Limited is Pharma.

Is Cureshot Pharmaceuticals And Research Center Private Limited a listed company?

Cureshot Pharmaceuticals And Research Center Private Limited is unlisted.

What is the capital structure of Cureshot Pharmaceuticals And Research Center Private Limited?

The authorized capital of Cureshot Pharmaceuticals And Research Center Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available